Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

Wyeth is now a wholly owned subsidiary of Pfizer750 enrolled

Overview

The purpose of this study is to investigate the incidence of adverse events for patients with AS treated with Enbrel in usual care settings.

Study Type

OBSERVATIONAL

Enrollment

750

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of ankylosing spondylitis Exclusion Criteria: * Contraindications according SmPC

Unnamed facility

Berlin, Germany

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.